Cost-Effectiveness Of Once-Daily Single-Inhaler Triple Therapy In COPD: The IMPACT Trial. (2019)
Attributed to:
Alpha-1-antitrypsin (AT) deficiency and the serpinopathies: pathobiology and new therapeutic strategies
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.2147/copd.s216072
PubMed Identifier: 31819401
Publication URI: http://europepmc.org/abstract/MED/31819401
Type: Journal Article/Review
Volume: 14
Parent Publication: International journal of chronic obstructive pulmonary disease
ISSN: 1176-9106